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Molecular dynamicsStructural and dynamic changes in cell membrane properties induced by xenon, a volatile anesthetic mole-
cule, may affect the function of membrane-mediated proteins, providing a hypothesis for the mechanism
of general anesthetic action. Here, we use molecular dynamics simulation and differential scanning calorim-
etry to examine the biophysical and thermodynamic effects of xenon on model lipid membranes. Our results
indicate that xenon atoms preferentially localize in the hydrophobic core of the lipid bilayer, inducing sub-
stantial increases in the area per lipid and bilayer thickness. Xenon depresses the membrane gel–liquid crys-
talline phase transition temperature, increasing membrane ﬂuidity and lipid head group spacing, while
inducing net local ordering effects in a small region of the lipid carbon tails and modulating the bilayer lateral
pressure proﬁle. Our results are consistent with a role for nonspeciﬁc, lipid bilayer-mediated mechanisms in
producing xenon's general anesthetic action.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
General anesthesia is a physiological state characterized by loss of
consciousness, loss of sensation through analgesic effects, immobili-
zation, and temporary amnesia [1]. The physiological effects are
known to be produced through depression of nerve function but, de-
spite the fact that general anesthesia has been accepted for clinical
use for over a century and is administered to approximately 21 mil-
lion patients annually in the United States alone [2], the speciﬁc mo-
lecular mechanisms by which anesthetic agents induce an anesthetic
state remain poorly understood.
The correlation between anesthetic efﬁcacy and lipid solubility,
known as the Meyer–Overton correlation [3,4], led the majority of re-
search on the molecular mechanisms of general anesthetics to be fo-
cused on the interactions between anesthetic agents and the lipid
bilayers of neuronal membranes for over 80 years. More recently,
however, a number of researchers, most notably Franks and Lieb [5],
have shifted the focus to direct protein interactions. Much research,
outlined extensively by Barash et al. [6], Urban [7,1], and Franks [8],
has focused on a mechanism involving direct interactions with hydro-
phobic pockets or clefts in transmembrane ion channels and protein
targets of general anesthetic agents are well supported by the evi-
dence. However, while signiﬁcant progress has been made in charac-
terizing the interactions between anesthetics and individual protein
and central nervous system (CNS) targets, these investigations have
not identiﬁed an individual target or comprehensive mechanism of
action capable of mediating the complete anesthetic effect [9]. In-
deed, it increasingly appears that the clinical effects of general+1 303 273 3730.
rights reserved.anesthesia are the result of multiple molecular mechanisms occurring
at different targets.
Of particular interest recently, both for its lack of undesirable side ef-
fects in clinical settings and for its unique molecular interactions, is the
noble gas xenon. The clinical viability of xenon as an anesthetic agent
has been known for over 60 years [10]. However, its clinical use has
been largely curtailed by its high cost until recently [11]. During the
last decade, the desire to replace or supplement the use of nitrous
oxide due to its environmental impacts [12] and the advantageous
pharmacokinetic proﬁle [13], neuroprotective properties [14,15], and
potent analgesic effects [16] of xenon have led to renewed interest in
xenon in clinical settings [11,17,18].
However, xenon's simple, spherical shape and the fact that it is es-
sentially inert pose an interesting conundrum in regard to the mech-
anisms of its anesthetic action. Xenon appears to have no signiﬁcant
effect on the most commonly implicated anesthetic target, GABAA
receptors [19–21]. Xenon has been shown to act on glutamatergic
receptors, with inhibition of NMDA receptors being the mechanism
implicated most often [19,22,20,23,24]. Using molecular dynamics,
Liu et al. [25] identify several potential action sites of xenon in
the ligand-binding domain of an NMDA receptor. However, results
with glutamatergic receptors have been somewhat inconsistent,
with other researchers showing that xenon acts on non-NMDA
glutamatergic receptors in Caenorhabditis elegans [26], although it is
possible that general anesthesia occurs by different mechanisms in
C. elegans versus humans and other mammals. Furthermore, recent
research has indicated that NMDA receptors do not mediate the
immobilizing effects of xenon and other inhaled anesthetics [27], al-
though this does not preclude the possibility that NMDA receptors
mediate the other effects of general anesthesia. It has also been
shown that one minimum alveolar concentration (MAC) of xenon
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whereas two anesthetics that have also been shown to inhibit
NMDA receptors, ketamine and nitrous oxide, increase cerebral
metabolism [27]. This inconsistency with anesthetic agents known
to interact with NMDA receptors may indicate that glutamatergic re-
ceptors play little or no role in the anesthetic effects of xenon in vivo
[28]. Xenon has also been shown to exert effects on nicotinic acetyl-
choline receptors [22] and certain potassium channels [30], some of
which have recently been implicated as playing a role in the anesthet-
ic effect [31,32], but the signiﬁcance of these results remains unclear.
Recently, there has been substantial renewed interest in the role
lipid bilayers play in modulating the function of membrane proteins
[33–36]. It has been shown that the open probability of voltage-
dependent potassium channels is affected by the mechanical state of
the surrounding lipid membrane [37] and that small changes in bilayer
thickness can reverse the response polarity of gramicidin A channels
[38]. Furthermore, amphiphiles have been shown to regulate voltage-
gated ion channel function through a lipid bilayer-mediated mecha-
nism [39,40] and GABAA receptor function is regulated by lipid bilayer
elasticity [41]. Cantor [42] proposed that an inhomogeneous modula-
tion of the lateral pressure (more accurately called the stress virial) pro-
ﬁles in the cellular membrane by anesthetic molecules exerts lateral
forces on transmembrane gated ion channels, inducing effects on chan-
nel current by increasing the energy needed to change the channel be-
tween open and closed conformations. Other recent studies have since
shown that a change in the lateral pressure proﬁle could inﬂuence the
conformation of ion channels [43,44] and molecular dynamics simula-
tions with ethanol and 1-alkanols have indicated that this mechanism
is consistent with the action of general anesthetics [45,46]. Further-
more, this hypothesis predicts the alkanol cutoff effect and anomalously
low anesthetic potencies of strongly hydrophobic molecules such as
perﬂuorocarbons.
It is generally accepted that cellular membranes in vivo can be de-
scribed by a ﬂuid mosaic model, proposed by Singer and Nicolson
[50], in which proteins are embedded within a lipid bilayer and all
components can diffuse laterally within the plane of the membrane
[51]. The accumulation of a variety of small molecules in a lipid bilay-
er is known to cause changes in the bilayer biophysical and thermo-
dynamic properties and these interactions between small molecules
and lipid bilayers have commonly been studied through computer
simulation. Molecular dynamics studies have primarily focused on
small hydrocarbons and organic acids [52–55], sugars [56–59], alco-
hols [60,54,61,45,62], and some small biological molecules [63,64].
Molecular dynamics studies of interactions betweengeneral anesthet-
ic agents and lipid membranes have been more limited in scope. Older
simulations were generally restricted to coarse-grained simulations
[65], short timescales [60,66–68] or studies solely of alcohols [60,61,45].
However, more recently, a number of atomistic simulation studies
conducted over longer timescales have indicated substantial effects of an-
esthetic agents on a number of lipid bilayer properties. Stimson et al. [69]
performed 100 ns, atomistic molecular dynamics simulations investigat-
ing the interactions between xenon and dioleoylphosphatidylcholine
(DOPC) bilayers, with initial results indicating that partitioning of xenon
into the bilayer causes small increases in the area per lipid and orienta-
tional order of the lipid acyl chains. More recently, Yamamoto et al. [70]
reported anMD study of POPE bilayer exposed to xenon at different pres-
sures to probe the pressure reversal effect in general anesthesia. The re-
sults from their simulations showed that pressure had little effect on
the properties of the lipid bilayer, but suggested that xenon accumulated
in the middle of the lipid bilayer and had its diffusivity substantially de-
creased. Simulation studies conducted by Tu et al. [71], studying halo-
thane, and Darvas et al. [72], studying halothane, chloroform, diethyl
ether, and enﬂurane, show reversal of the effects of general anesthetic
agents on membrane properties at high pressures.
Here, we investigate the interactions of xenon with model phos-
pholipid membranes using molecular dynamics (MD) simulations ofpure DOPC bilayers in two initial conﬁgurations with xenon at a
range of concentrations and pressures and over timescales of 150–
300 ns. Differential scanning calorimetry (DSC) measurements are
presented to characterize the effects of xenon on lipid membrane
phase transition temperatures and ﬂuidity. Xenon is shown to exert
broad biophysical effects on membrane ﬂuidity, lateral pressure pro-
ﬁles near the lipid head groups, and bilayer structure. These interac-
tions are consistent with a lipid bilayer-mediated mechanism of
general anesthetic action.
2. Materials and methods
2.1. Molecular dynamics simulations
Molecular dynamics simulations were performed on two different
types of systems: 1) single bilayer systems containing 288 DOPC mole-
cules arranged in a bilayer structure (144 molecules in each leaﬂet);
and 2) double bilayer systems containing 576DOPCmolecules arranged
in two bilayers, separated by aqueous phases. A DOPCmoleculewas ini-
tially constructed and then arranged in a bilayer conﬁguration (Fig. S1
in the Supporting material is a line diagram of a DOPC molecule). A
total of six xenon concentrations were simulated: 0, 1, 1.5, 2, 2.5, and
3 xenon atoms per lipid. The minimum alveolar concentration (MAC)
for xenon is 71% [73]. Stimson et al. [69] point out that the speciﬁc con-
centration, in a tissue comparable to those simulated here, required to
induce an anesthetic state is unknown and this remains true. The con-
centrations chosen here are comparable to those used in previous stud-
ies [69,70].
Bilayers were fully hydrated, with 40 water molecules per lipid in
the systems containing xenon concentrations of 0 to 2 xenon atoms
per lipid and 50 water molecules per lipid in the systems containing
2.5 and 3 xenon atoms per lipid. Prior to insertion of xenon atoms,
the bilayers were heated to 450 K to erase memory effects from the
initial conﬁguration. Bilayers were then allowed to equilibrate for
20 ns at 310 K. Initial conﬁgurations were generated by adding a
number of excess water molecules equal to the intended number of
xenon atoms, then randomly replacing the appropriate number of
water molecules with xenon atoms. Fig. 1 shows snapshots of the ini-
tial (A) and ﬁnal (B) conﬁgurations of a double bilayer system. Fig. 3B
shows a snapshot of a single bilayer system and Fig. S3 shows snap-
shots of the initial (A) and ﬁnal (B) conﬁgurations of a single bilayer
system. For the results below, data were analyzed over the last
20 ns for single bilayer simulations and over the last 40 ns for double
bilayer systems, when the systems had reached dynamic equilibrium.
The systems reached dynamic equilibrium when net diffusion of
xenon between the bilayer and aqueous phases ceased and when
changes in bilayer surface area over time stabilized around a mean
value (this was true over the ﬁnal 20 ns for all single bilayer systems
and over the ﬁnal 40 ns for all double bilayer systems). An example of
the distribution of xenon between the aqueous phase and lipid bilay-
er in a double bilayer is shown in Fig. S4.
The forceﬁeld employed for the lipids used the Berger lipid param-
eters [74] with the GROMOS forceﬁeld. Water was represented by the
single point charge (SPC) model [75] and the xenon atoms were rep-
resented as simple Lennard–Jones sites with ε=1.837 kJ/mol and
σ=0.410 nm [76]. This approach is consistent with previous MD
simulations of lipid bilayers and with simulations of bilayers with
xenon speciﬁcally [69,70]. Simulations were performed using single
precision GROMACS 4 [77] with the Berendsen thermostat and
barostat [78]. Simulations were held at a constant temperature of
310 K, above the Lβα (gel–liquid crystalline) phase transition temper-
ature for DOPC (−20 °C [79]), and four different pressures were
used: 1, 50, 100, and 200 bar. Anisotropic pressure coupling was ap-
plied. A short range cut-off of 1.0 nm was used for nonbonded inter-
actions (Coulombic and Lennard-Jones) and long-range electrostatic
interactions were calculated by the particle-mesh Ewald method
Fig. 1. Illustration of a double DOPC bilayer system in the MD simulations. (A) Initial conﬁguration with xenon in the aqueous phase. (B) Final conﬁguration with xenon at equi-
librium partitioning between bilayer and aqueous phases. Carbon (gray), oxygen (green), nitrogen (blue), and phosphorous (yellow) in head groups are shown using a licorice rep-
resentation while the lipid tails are shown as lines. Xenon is represented by orange spheres. Water molecules are not shown for clarity.
1349R.D. Booker, A.K. Sum / Biochimica et Biophysica Acta 1828 (2013) 1347–1356[80,81]. A time-step of 2 fs was used for all simulations and the LINCS
algorithmwas used to apply bond constraints [82]. Periodic boundary
conditions were applied in all directions.
2.2. Liposome preparation
In order to further investigate the effects of xenon onmembraneﬂu-
idity and correlate these results to the simulation studies, model cell
membranes consisting of dielaidoylphosphatidylcholine (DEPC) lipo-
somes (large multilamellar vesicles) were prepared (Fig. S2 in the
Supporting material is a line diagram of a DEPC molecule). DEPC un-
dergoes an Lβα (gel–liquid crystalline) phase transition at 12 °C [79].
DEPC [18:1 Δ9-trans phosphocholine] was obtained from Avanti Polar
Lipids (Alabaster, AL) in powder form. Liposomes (multilamellar vesi-
cles) were prepared by dissolving 20 mg/mL of powdered lipids into
deionized water. Lipids were vigorously mixed for 1 h and the lipo-
somes were then allowed to age overnight at approximately 20 °C.
After aging, the large multilamellar vesicles were stored at approxi-
mately 20 °C (above the DEPC phase transition temperature) and
used within 48 h.
2.3. Differential scanning calorimetry
Todetermine the effects of xenon onmembraneﬂuidity, the Lβα (gel–
liquid crystalline) phase transition temperature was determined at
xenon pressures of 3 and 10 bar using a high-pressure microdifferential
scanning calorimeter (μ-DSC VIIa, Setaram Inc.). DEPCwas used for these
experiments due to its higher phase transition temperature than the
simulated lipid, DOPC. Samples of 25–30 mg were placed in a Hastelloy
C276 cell with a ﬁxed internal volume of 0.5 mL. The sample cell and a
reference cell were connected to a xenon cylinder (99.999% pure from
Matheson Tri-Gas) through a custom-designed high-pressure panel.
Heating and cooling of the cells were achieved using Peltier heating
elements.
The procedure for the DSC measurements was as follows. Samples
were pressurized to the selected xenon pressure at 30 °C. The tem-
perature was then ramped to −2 °C at 1 °C/min and held at −2 °C
for 10 min. The temperature was then ramped back to 30 °C, with a
heating rate of 0.3 °C/min. Heating and cooling cycles were repeated,
with one measurement of Tm per cycle, until equilibrium, as indicated
by a lack of change in the phase transition temperature, was reached.Tmwas measured during heating cycles (Lβα phase transition) and the
liposome phase transition region was thus indicated by an endother-
mic heat ﬂow peak. The phase transition temperature was deter-
mined as the minimum of the endothermic heat ﬂow peak.3. Results
3.1. Xenon partitioning and effects on lipid tail ordering
At dynamical equilibrium, approximately 97% of the xenon atoms
localize within the bilayer. Fig. 1B shows an example of the ﬁnal conﬁg-
uration of a double bilayer system in which xenon has permeated into
the membrane, leaving approximately 3% of the xenon atoms in the
bulk aqueous phase. Neither the xenon concentration in the system
nor the system pressure substantially affects the xenon partitioning
between the aqueous phase and bilayer at equilibrium (see the
Supporting material for a discussion on the dynamics of xenon perme-
ation into the bilayers). The GROMOS forceﬁeld utilized here does not
incorporate the polarizability of xenon, which is important to its behav-
ior, particularly in aqueous systems. Xenon's high polarizability (4)
compared to the other noble gases increases its afﬁnity for hydrophobic
environments. It is thus interesting to note the substantial partitioning
of the xenon into the hydrophobic core of the bilayer despite the lack
of polarizability in the forceﬁeld.
The partitioning of the xenon atoms within the lipid bilayer sys-
tems can be more quantitatively assessed by examining the partial
densities of the systems at equilibrium (see Fig. S5 in the Supporting
material for the component densities for water, DOPC, the phospho-
rous atoms of the DOPC head groups, and xenon at three concentra-
tions). For this work, the interior of the bilayer is deﬁned as the
region between the phosphorus atoms in the lipid head groups of
the two bilayer leaﬂets (see Fig. S5 in the Supporting material).
Xenon is found to preferentially localize in the hydrophobic core of
the bilayer, below the lipid head groups. The region of highest
xenon density occurs between the cis double bonds and the terminal
carbon atoms in the lipid acyl chains, although a substantial amount
of xenon does localize in the gap region between the terminal car-
bons. This localization of xenon within the hydrophobic core of the
lipid bilayer was also found in previous simulation studies by Stimson
et al. [69] and Yamamoto et al. [70].
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has substantial implications for the ordering of the lipid acyl chains.
Fig. 2B shows the lipid tail deuterium order parameters at each of
the six xenon concentrations that were simulated. The order parame-
ter [83] provides a quantitative measure of the alignment of the lipid
tails. Increasing xenon concentration causes a corresponding increase
in the ordering of the lipid tails, primarily between the cis double
bonds of the acyl tails and the terminal carbons, in the regions corre-
sponding to the highest xenon density. The increase in the order pa-
rameters indicates a more ordered and constrained environment for
the acyl chains, resulting in a relative decrease in membrane ﬂuidity
from the cis double bonds to the terminal carbons.
3.2. Effects of xenon on membrane structure
Fig. 3A shows the relationship between area per lipid and increasing
xenon concentration. The area per lipid is deﬁned as the area of the
xy-plane of the simulation box divided by the number of lipids per leaf-
let, as shown in Fig. 3B. Again, pressure does not substantially affect the
bilayer surface area because the bilayers are essentially incompressible.
The value for the area per lipid at 1 bar for a pure DOPC bilayer (no
xenon) agrees closely with previous results obtained by Alwarawrah
et al. [84], differing by 3.1% or 0.02 nm2. The trend of increasing bilayer
surface area with increasing xenon concentration is also reported by
Stimson et al. [69] and Yamamoto et al. [70]. The observed simultaneous
increase in the area per lipid and in the ordering of the acyl chains (com-
parison between Figs. 2B and 3A) with increasing xenon concentration
is a counterintuitive trend. In general, increased bilayer surface area is
accompanied by decreased acyl chain ordering, resulting in increased
membrane ﬂuidity. The constraining of the lipid tails indicative of in-
creased order parameter corresponds to increased lipid packing and
thus decreased bilayer surface area. This apparent inconsistency appears
to be the result of two competing effects when xenon is present in the
lipid bilayer, which are elucidated by the differential scanning calorim-
etry results and will be discussed later in the paper.
Localization of xenon within the lipid membrane also causes an
increase in bilayer thickness, shown in Fig. 3C (this is also observed
as an increase in the distance between the peaks in Fig. S5 in the
Supporting material). In Fig. 3D, the total area of the bars indicates
the change in bilayer thickness at each xenon concentration from
the thickness when no xenon is present, while the smaller, darkly
shaded areas represent the portion of the total change in thickness0 3 6 9 12 15 18
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ly with increasing xenon concentration, with an increase of approxi-
mately 0.45 nm observed from no xenon to 3 xenon per lipid. As
shown in Fig. 3D, an increase in the gap between the terminal carbons
accounts for 75–85% of the total increase in bilayer thickness. The
remaining increase in bilayer thickness is likely caused by the
straightening of the lipid acyl chains due to increased order parame-
ter. While no pressure effects were observed for the lipid tail order
parameters or bilayer surface area, at the highest pressure (200 bar)
and high xenon concentration (2.5–3.0 xenon per lipid), there is a
small increase in bilayer thickness. This increase in thickness is en-
tirely accounted for by an increase in the gap between the terminal
carbons, thus explaining the increase in thickness without a statisti-
cally signiﬁcant corresponding decrease in bilayer surface area.
Thus, the accumulation of xenon in the membrane induces mem-
brane swelling through increases in both bilayer thickness and surface
area. This swelling is accompanied by a decrease in lipid occupied vol-
ume within the membrane, which is evident from a decrease in the
DOPC density within the core of the bilayer with increasing xenon con-
centration (see Fig. S6 in the Supporting material).
3.3. Effects of xenon on lipid phase transition and ﬂuidity
In order to determine the effects of the accumulation of xenon on
the main (Lβα, gel to liquid crystalline) phase transition temperature
(Tm) and ﬂuidity of lipid membranes, we conducted a series of DSC
measurements on large multilamellar vesicles (LMVs) in the presence
of xenon gas. Dielaidoylphosphatidylcholine [DEPC, 18:1 Δ9-trans
phosphocholine] was used in these measurements, rather than
DOPC [18:1 Δ9-cis phosphocholine] used in the molecular dynamics
simulations, due to its higher phase transition temperature. Pure
DOPC liposomes undergo a phase transition at approximately −
20 °C [79], which is low enough below the freezing point of water
that it is very difﬁcult to prevent freezing of water during the cooling
stage in the DSC measurements. DEPC, however, undergoes an Lβα
phase transition at approximately 12 °C [79], allowing DSC scans
above the freezing point of water, resulting in clean and clear scans
of the phase transition heat ﬂow.
The Lβα phase transition temperature for the pure DEPC liposomes,
measured prior to charging with xenon, was found to be 11.8±0.4 °C,
within experimental error of the accepted value of 12 °C [79]. Fig. 4A10 12 14 16
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creasing time for DEPC liposomes exposed to xenon gas at 10 bar.
Each peak represents the heat ﬂow curve from a different tempera-
ture cycle, with each cycle occurring approximately 2.6 h apart. The
Lβα phase transition temperature decreased substantially during the
ﬁrst cycle, dropping to approximately 5.5 °C, followed by a steady de-
crease in Tm until an equilibrium value of 4.8±0.4 °C was reached.
Thus, the Lβα phase transition temperature for DEPC liposomes de-
creases 7.0 °C when at equilibrium with xenon at 10 bar.
Xenon is also a clathrate hydrate former and under the conditions of
this study, these crystalline structures are easily formed. After reaching
an equilibrium concentration of xenon in the bilayer, xenon clathrate
hydrate formation was induced in the liposome–xenon system by a fur-
ther temperature decrease to−10.0 °C. Formation of xenon hydrates in
the liposome solution was evident from exothermic and endothermic
heat ﬂow peaks, representing hydrate formation and dissociation, re-
spectively, in a similar manner to that described in [85] (see Fig. S7 inthe Supportingmaterial for hydrate dissociation curves). In the presence
of xenon hydrates, the DEPC liposomes Tm shifted to 9.2±0.4 °C (see
Fig. 4B) for xenon charged to 10 bar. Similar results were found when
xenon was charged to 13 bar and 17 bar. The similar transition temper-
atures found for the three different pressures in thepresence of clathrate
hydrate is likely due to the increased formation of xenon hydrate at
higher pressures, leaving similar amounts of xenon available for perme-
ation into the liposomes at the three pressures. This is the ﬁrst instance
that the thermodynamics of these liposome–xenon clathrate hydrate
systems have been measured. The increase in the Lβα phase transition
temperature when xenon clathrate hydrate is formed versus when it is
not suggests that the change in liposome Tm induced by xenon is con-
centration dependent. As the clathrate hydrate is formed, a signiﬁcant
amount of xenon is enclathrated in the crystalline structure, not only re-
ducing the available concentration of xenon for permeation into the li-
posomes, but also removing xenon from the liposomes. This apparent
concentration dependence was further explored by repeating the Tm
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Fig. 4. Thermograms of DEPC liposome Lβα phase transition temperatures in the presence of xenon. (A) Change in phase transition temperature over time for liposome exposed to
xenon at 10 bar. Each heat ﬂow peak represents a different cycle. Cycle length was 2.6 h. (B) Phase transitions for liposome under different conditions corresponding to xenon at
10 bar, xenon hydrates formed at 10 bar, and vented xenon. (C) Pressure (concentration) dependence of phase transitions for liposome. The phase transition after venting xenon
was identical for the 3 and 10 bar conditions.
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riumwith xenon at 3 bar, the DEPC liposomes' Tmwas found to be 9.3±
0.4 °C, a decrease of only 2.5 °C from the pure DEPC liposomes Tm. Thus,
it is clear that the effect of xenon on the Lβα phase transition tempera-
ture of liposomes is concentration dependent. The values for Tm are
summarized in Table 1.0
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Cantor [42] proposed that an inhomogeneous modulation of the
lateral pressure proﬁles in the cellular membrane by anesthetic mol-
ecules changes the lateral forces exerted on transmembrane gated ion
channels, inducing effects on channel current by increasing the ener-
gy needed to change the channel between open and closed conforma-
tions. Fig. 5 shows the lateral pressure proﬁle for a DOPC bilayer with
xenon at several concentrations and details the associated changes
induced by xenon on the properties of the bilayers.
Substantial lateral pressure, particularly in the region approxi-
mately 1.5 to 2.5 nm from the bilayer center (near the lipid head
groups), is observed. The positive peak at the membrane–water inter-
face (~±2.6 nm) is generally interpreted as being due to repulsion
due to electrostatic and steric interactions, as well as a hydration re-
pulsion component [45]. Unlike the ﬁndings for ethanol [45], this
peak appears to be largely unchanged by the accumulation of xenon
in the bilayer. Closer to the bilayer center (~±1.5–2.0 nm), there is
a region characterized by substantial negative pressure, indicating
an attractive contribution due to interfacial energy between waterTable 1
Gel–liquid crystalline (Lβα) phase transition temperatures and phase transition range
for DEPC liposomes obtained from DSC measurementsa.
Sample Tm (°C)b Tlower (°C)c Tupper (°C)c Range (°C)
No xenon 11.8 11.7 12.2 0.5
Xe at 3 bar (no hydrate) 9.3 8.5 10.1 1.6
Xe at 10 bar (no hydrate) 4.8 3.3 6.4 3.1
Xe at 10 bar (with hydrate) 9.2 8.9 9.6 0.7
Xe at 13 bar (with hydrate) 9.2 8.9 9.6 0.7
Xe at 17 bar (with hydrate) 9.4 8.8 10.0 1.2
Xenon vented 11.4 11.0 11.8 0.8
a Error (based on SD) in temperature measurements is ±0.4 °C.
b The value for the phase transition temperature (Tm) is the minimum of the heat
ﬂow.
c The lower (Tlower) and upper (Tupper) phase transition temperatures are taken as
the onset and return, respectively, of heat ﬂow deviation from the baseline.and the hydrophobic core of the bilayer. Unlike in previous simulation
studies, this negative peak is found to be bimodal. This bimodal re-
sponse may originate from additional interactions at the region be-
tween the lipid head groups and hydrophobic core being captured.
As with the results of Terama et al. [45] for ethanol, the magnitude
of this peak is reduced by approximately 100 to 200 bar by the pres-
ence of xenon. This reduction is increased at higher xenon concentra-
tions (2.5 and 3 xenon per lipid) but that data are not shown because
the expansion of the bilayer makes comparison with the other lateral
pressure proﬁles difﬁcult. This decrease in the magnitude of the neg-
ative peak is likely caused by a decrease in surface tension between
water and the hydrophobic core of the bilayer due to the presence
of xenon at and near this interface.
There is substantial modulation of the lateral pressure proﬁle near
the regions where xenon primarily localizes at equilibrium (the-3 -2 -1 0 1 2 3
Distance from bilayer center (nm)
-1000
-500Pr
Fig. 5. The lateral pressure proﬁle for a DOPC bilayer at 1 bar and 310 K with xenon at
several concentrations. The higher xenon concentrations (2.5 and 3 xenon per lipid)
are not shown due to the large change in bilayer thickness. To calculate the lateral
pressure proﬁles, the trajectories from the 150 ns single bilayer simulation runs were
analyzed using the 3D pressure ﬁeld method developed by Ollila et al. [86]. The ﬁnal
30 ns of the simulation runs were used in the analysis. This method involves the calcu-
lation of the lateral pressure proﬁle from the Irving–Kirkwood contour [87] by
discretizing the local pressure into small cubes, allowing for calculation of the average
pressure over arbitrary volume elements. Coloring of lines corresponds to xenon con-
centrations of 0.0 (black), 1.0 (blue), 1.5 (red), and 2.0 (green) xenon per lipid.
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much nearer the lipid head groups, no reduction in the positive
peak at the membrane–water interface is observed because the low
concentrations of xenon near the lipid head groups are unable to
screen electrostatic interactions between the head groups as the
higher concentrations of ethanol do. While modulation of the lateral
pressure proﬁle as a mechanism for general anesthesia is theoretically
consistent with current understanding of the general anesthetic ef-
fect, the speciﬁc effects of lateral pressure on transmembrane pro-
teins are unclear and signiﬁcant experimental and simulation work
will be needed to further elucidate this effect. It has been hypothe-
sized that the shape of some ion channels may be inﬂuenced by
changes in surrounding membrane properties or that changes in
membrane properties may inﬂuence the energy required for a trans-
membrane ion channel to undergo a conformational change [34,36],
but the implications for xenon's anesthetic effect remain conjecture.
However, if modulation of the lateral pressure proﬁle does play a
role in mediating the general anesthetic effect, the reduction in the
magnitude of the negative peak near the hydrophobic core, as with
ethanol, and the lack of an effect on the peak near the membrane–
water interface, in contrast with ethanol, indicates that the lateral
pressure near the hydrophobic core may be a key in modulating ion
channel function.
5. Reversibility of xenon effects
After equilibrium was reached at both 3 and 10 bar in the DSC ex-
periments, a ﬁnal set of measurements was taken to determine Tm
after venting xenon from the system (see Fig. 4B and C and
Table 1). Within an hour of xenon being removed from the system,
the DEPC Tβα phase transition temperature was measured to be
11.4±0.4 °C. While this value is within experimental error of Tm for
pure DEPC liposomes prior to charging within xenon, it is likely that
Tm is, in fact, slightly lower after venting xenon due to the residual
amount of xenon in the system (a longer wait time after venting
xenon would probably return the Tm to its original value of 11.8 °C).
This rapid increase in Tm upon removal of xenon from the system in-
dicates that the effects of xenon on Tm, and thus the ﬂuidity, which
are closely related, of lipid membranes are reversible.
To conﬁrm the reversibility of the effects of xenon on lipid mem-
branes, MD simulations were performed using the ﬁnal conﬁgurations
of the 200–300 ns double bilayer runs as starting conﬁgurations. The
simulation parameters and setup were the same as those discussed in
the Materials and methods section. In these simulations, xenon was
manually removed from the aqueous phase but allowed to remain inside
the bilayer and simulations were then run until a new equilibrium was
reached, determined by monitoring the distribution of xenon in the bi-
layer and aqueous phase. Xenon was then removed from the aqueous
phase again, and the simulations repeated. This processwas done succes-
sively and the changes in bilayer properties were analyzed. Fig. S8 in the
Supportingmaterial shows the distribution of xenon between the bilayer
and the aqueous phase for a xenon removal simulation. As expected
based on the reversibility of the effects of xenon on liposome phase tran-
sition temperatures and in clinical usage, the xenon partitioned out of
the bilayer, coming to a new equilibrium between the bilayer and the
aqueous phase. As this repartitioning occurs, the properties of the lipid
bilayer return toward their original values.
5.1. Discussion and conclusions
The combined results of the MD simulations and the DSC measure-
ments provide a complex picture of the interactions between xenon
and lipid membranes and the implications for membrane properties.
It is clear that xenon, aswith other small molecules [53,56,54,61,45], in-
duces substantial structural changes in lipid membranes. The increase
in area per lipid in the presence of xenon shown by theMD simulationsindicates a concomitant increase in membrane ﬂuidity. The substantial
reduction in liposome phase transition temperature in the presence of
xenon also indicates an increase in membrane ﬂuidity and in bilayer
surface area, consistent with the increase in area per lipid found in the
MD simulations. Furthermore, as shown in Fig. 4A and Table 1, the Tm
heat ﬂow peaks shorten and widen as xenon permeates into the lipo-
somes, suggesting a more inhomogeneous environment while the lipo-
somes transition from the gel to the liquid–crystalline phase. As shown
in Table 1, the phase transition temperature range increases by asmuch
as 600% at a xenon pressure of 10 bar and, even at a relatively low
xenon pressure of 3 bar, the presence of xenon still induces substantial
widening of the phase transition region. This widening of the phase
transition region has been shown for a variety of other small molecules
[88], including several serotonin receptor agonists [89] and the anes-
theticsmethoxyﬂurane [90], halothane, and enﬂurane [91].Wepropose
that thewidening of the phase transition region induced by xenon is the
result of an increase in the membrane surface area. The increased spac-
ing between lipid head groups disrupts the continuum of the bilayer,
broadening the phase transition, which is known to be a highly cooper-
ative process [92,93].
A similar decrease in the membrane phase transition temperature
has been shown experimentally for several other anesthetic agents.
Trudell et al. [90] showed that clinical concentrations of methoxyﬂu-
rane decreased the gel–liquid crystalline phase transition of mixed
DPPC–DMPC bilayers. Similar results were reported by Mountcastle
et al. [91] for halothane and enﬂurane with multilamellar DPPC lipo-
somes. It is important to note, however, that not all small molecules
induce changes in membrane phase transition temperature. Cater et
al. found small to negligible effects of a variety of drugs, including
morphine, on lipid phase transition temperatures [94].
As mentioned previously, the area per lipid in the bilayers increases
signiﬁcantly despite small increases in the order parameter of the lipid
acyl chains (which was also reported by Stimson et al. [69]), a change
normally associated with increased lipid packing and decreased bilayer
surface area. The increase in surface area and membrane ﬂuidity are
conﬁrmed by the DSC results. Furthermore, a simulation designed to as-
sess the impact of the observed bilayer swelling on tail order parameter
showed a substantial decrease in order parameter when themembrane
swelled, independent of the other effects of xenon (see Fig. S9 in the
Supporting material for additional information). Thus, we propose that
the increased order parameter found in the simulation results repre-
sents a net local increase in ordering of the lipid acyl chains in the region
between the cis double bonds and the terminal carbons, partly account-
ing for the observed increase in bilayer thickness. The increase in mem-
brane ﬂuidity associated with the increase in surface area occurs partly
due to depression of the Lβα phase transition temperature, which is
not well captured by the DOPC model used in the simulations. The sig-
niﬁcant number of xenon atoms present in the hydrophobic core of
the bilayer exert steric-like effects on the surrounding acyl chains, forc-
ing an increase in order and straightening of the tails but simultaneously
inducing an increase in the lipid head group spacing. Using electron
paramagnetic resonance techniques, Chin et al. [95] demonstrated that
high pressure gases, including xenon, induced two effects in spin-
labeled phospholipid bilayers: 1) initially, ordering in the bilayer
increased, decreasing molecular motion in the plane of the bilayer, in a
manner related to the increase in pressure; 2) on longer time scales,
membrane ﬂuidity was found to increase in a manner roughly
corresponding to the lipid solubility of the gas. Thus, we propose that
the accumulation of xenon in the bilayer decreases the lipid occupied
volume within the membrane as a result of membrane swelling while
simultaneously inducing net local ordering effects in a small region of
the bilayer tails.
These results have substantial and signiﬁcant implications for the
potential of membrane-exerted effects on integral membrane pro-
teins induced by xenon. The decrease in phase transition temperature
caused by xenon is consistent with Heimburg's hypothesis of lipid
Local chain 
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Lipid head group 
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Bilayer thickness 
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Hydrophobic 
mismatch
Membrane fluidity 
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Head group
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Modulation of lateral 
pressure profile
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Fig. 6. Schematic representation of major changes in bilayer properties induced by xenon and hypothesized impacts on an ion-gated channel. (A) Lipid bilayer and ion channel prior
to permeation of xenon. In the absence of xenon, the channel is in an open conformation, allowing the ﬂux of ions. (B) Changes in bilayer properties when accommodating xenon
and hypothesized membrane-mediated effects on the ion-gated channel. Ion ﬂux through the channel is signiﬁcantly reduced or completely stopped. Purple circles are lipid head
groups, black lines are lipid tails, orange circles are xenon atoms, and green circles are ions.
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volatile anesthetics [47–49]. However, Heimburg's hypothesis has a
number of ﬂaws. Most signiﬁcantly, while changes in temperature
have been shown to induce substantial changes in lipid membrane
ﬂuidity, changes in temperature do not induce an anesthetic state
and, as is acknowledged by Heimburg, application of anesthesia at
temperatures substantially different than 310 K does not substantial-
ly change anesthetic potency. Thus, changes in membrane ﬂuidity do
not appear to be the main mechanism by which general anesthesia is
induced. However, increases in membrane ﬂuidity do affect the local-
ization of membrane proteins, which has been implicated as mediat-
ing a number of cellular processes [96].
The thermodynamic and biophysical structural changes induced by
xenon also alter the bilayer lateral pressure proﬁle in the region of the
bilayer head groups (see Fig. 5), consistent with Cantor's hypotheses
on lipid membrane-induced anesthesia through modulation of the bi-
layer lateral pressure proﬁle [42] and previous simulation results with
ethanol [45]. The modulation of the membrane lateral pressure proﬁle
by xenon provides a mechanistic hypothesis for anesthetic action with
xenon. This hypothesis accounts for, and indeed predicts, the violations
of theMeyer–Overton correlation that have commonly been used as ev-
idence against an indirect, lipid-bilayermediatedmechanismof general
anesthesia [97].
However, a number of questions remain unresolved for Cantor's hy-
pothesis. Indeed, the mechanism by which changes in lateral pressure
proﬁlewould induce changes in transmembraneproteinsmust be further
explored. An analysis by Phillips et al. [36] indicates that membrane-
deformation free energy can potentially compete with the driving force
for channel gating, thereby inﬂuencing the protein conformation. Thus,
they conclude that, while themanner inwhich a speciﬁc protein interacts
with a lipid membrane is highly speciﬁc, it is reasonable to expect that
membrane proteins that alter their footprint within the membrane dur-
ing a conformational change will be dependent on the structure of the
membrane. However, speciﬁc protein targets for a lipid membrane-
mediated mechanism of general anesthetic action have not been pro-
posed so this mechanism remains speculative. Furthermore, as of yet,
Cantor's lateral pressure proﬁle hypothesis does not account for the fact
that some general anesthetic agents, such as isoﬂurane [98,99], are chiral
molecules, with different enantiomers exhibiting different anesthetic po-
tencies. While chiral molecules do exist in many membranes, no lipid
membrane-mediated mechanism accounting for the observed stereo-
speciﬁcity has been proposed [42]. Indeed, research by Dickinson et al.
[100], among others, has indicated that it is not likely that chiral mole-
cules in lipid membranes play a role in this stereospeciﬁcity. This argu-
ment does not apply to xenon as xenon is not a chiral molecule at
physiological conditions but does limit the general applicability of the lat-
eral pressure proﬁle hypothesis in its current form.The signiﬁcant changes in lipid bilayer properties induced by xenon
and the hypothesized effects on a gated ion channel are schematically
summarized in Fig. 6. As illustrated, we suggest that gated ion channel
function is indirectly impacted by the accumulated xenon in the mem-
brane, which induces conformational changes in the ion channel,
resulting in an altered ﬂux of ions through the channel. The depression
of the phase transition temperature, modulation of lateral forces on the
channel, and inducement of hydrophobic mismatch due to membrane
swelling each provide mechanisms for indirect action on ion channel
conformation and function. Additionally, results of the calorimetry
measurements and a set of MD simulations designed to test the revers-
ibility of xenon's effects on lipid membranes are consistent with the
clinical reversibility of the effects of general anesthesia. None of these
ﬁndings preclude the possibility that general anesthetic agents, includ-
ing xenon, interact directlywith proteins to induce the effects of general
anesthesia. Indeed, given the large body of evidence, it is likely that di-
rect protein interactions are involved in mediation of the general anes-
thetic effect. However, our results suggest that a lipid bilayer-mediated
mechanismmay also play a role inmediating someor all of the effects of
general anesthesia induced by xenon.
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